作者：
Wei-Yu,Lin [1]
;
Sarah E,Fordham [1]
;
Nicola,Sunter [1]
;
Claire,Elstob [1]
;
Thahira,Rahman [1]
;
Elaine,Willmore [1]
;
Colin,Shepherd [1]
;
Gordon,Strathdee [1]
;
Tryfonia,Mainou-Fowler [1]
;
Rachel,Piddock [1]
;
Hannah,Mearns [1]
;
Timothy,Barrow [2]
;
Richard S,Houlston [3]
;
Helen,Marr [4]
;
Jonathan,Wallis [4]
;
Geoffrey,Summerfield [5]
;
Scott,Marshall [6]
;
Andrew,Pettitt [7]
;
Christopher,Pepper [8]
;
Christopher,Fegan [9]
;
Francesco,Forconi [10]
;
Martin J S,Dyer [11]
;
Sandrine,Jayne [11]
;
April,Sellors [11]
;
Anna,Schuh [12]
;
Pauline,Robbe [12]
;
David,Oscier [13]
;
James,Bailey [14]
;
Syed,Rais [14]
;
Alison,Bentley [15]
;
Lynn,Cawkwell [16]
;
Paul,Evans [17]
;
Peter,Hillmen [18]
;
Guy,Pratt [19]
;
David J,Allsup [20]
;
James M,Allan [21]
作者单位：
Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
[1]
Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK.
[2]
Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
[3]
Department of Haematology, Freeman Hospital, Newcastle upon Tyne, UK.
[4]
Queen Elizabeth Hospital, Gateshead, UK.
[5]
City Hospitals Sunderland NHS Trust, Sunderland, UK.
[6]
University of Liverpool, Liverpool, UK.
[7]
Brighton and Sussex Medical School, University of Sussex, Brighton, UK.
[8]
Institute of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
[9]
Cancer Sciences Unit, Cancer Research UK and NIHR Experimental Cancer Medicine Centres, University of Southampton, Southampton, UK.
[10]
The Ernest and Helen Scott Haematological Research Institute, Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
[11]
University of Oxford, Oxford, UK.
[12]
Royal Bournemouth Hospital, Bournemouth, UK.
[13]
Hull University Teaching Hospital NHS Trust, Hull, UK.
[14]
Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK.
[15]
University of Hull, Hull, UK.
[16]
Haematological Malignancy Diagnostic Service Laboratory, St James' Institute of Oncology, Leeds, UK.
[17]
Section of Experimental Haematology, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
[18]
University of Birmingham, Birmingham, UK.
[19]
Hull University Teaching Hospital NHS Trust, Hull, UK. hycda1@hyms.ac.uk.
[20]
Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK. hycda1@hyms.ac.uk.
[21]
Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. james.allan@newcastle.ac.uk.
[22]
DOI
10.1038/s41467-020-20822-9
PMID
33510140
发布时间
2024-03-06
换一批
换一批
